Global Infectious Substance Packaging Market Growth 2025-2031

Publication ID:

LPI06250336

Publication Date:

June 26, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Packaging Machinery [2]

Packaging [3]

Industry & Manufacturing [4]

Description:

The global Infectious Substance Packaging market size is predicted to grow from US$ 149 million in 2025 to US$ 217 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.
Infectious substance packaging refers to the specialized packaging designed to safely transport and contain materials that are known or suspected to contain infectious agents. These packaging systems are specifically designed to prevent the spread of pathogens and protect individuals from potential exposure to harmful microorganisms during transportation.
The infectious substance packaging global market refers to the market for packaging materials and solutions specifically designed to safely transport and handle infectious substances. This includes packaging and labeling requirements set by international and national regulations such as the United Nations (UN) Recommendations on the Transport of Dangerous Goods and the International Air Transport Association (IATA) Dangerous Goods Regulations. The market for infectious substance packaging is driven by the growing need to transport and handle infectious materials safely in various industries, including healthcare, pharmaceuticals, diagnostics, research laboratories, and biotechnology. This includes transporting specimens for diagnostic testing, shipping infectious samples for research purposes, and safely disposing of or transporting medical waste. Key players in the infectious substance packaging market offer a range of products such as biohazard bags, specimen transport bags, containers, vials, absorbent materials, and labels that comply with the required regulations. These packaging solutions are designed to prevent leakage, protect against contamination, and ensure the safety of individuals handling or coming into contact with infectious substances. The market is also influenced by advancements in packaging technologies, such as the development of leak-proof and tamper-evident packaging solutions, as well as the increasing adoption of automated packaging systems that improve efficiency and ensure compliance with regulations. Geographically, the infectious substance packaging market is global in nature, with companies operating internationally to meet the demands of various industries and comply with different regulatory frameworks. The market is expected to continue growing as awareness of the importance of safe handling and transportation of infectious substances increases and as regulations become more stringent to ensure public and environmental safety.
The 鈥淚nfectious Substance Packaging Industry Forecast鈥� looks at past sales and reviews total world Infectious Substance Packaging sales in 2024, providing a comprehensive analysis by region and market sector of projected Infectious Substance Packaging sales for 2025 through 2031. With Infectious Substance Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Substance Packaging industry.
This Insight Report provides a comprehensive analysis of the global Infectious Substance Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Substance Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Infectious Substance Packaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Substance Packaging and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Substance Packaging.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Substance Packaging market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
UN2814
UN2900
UN3373
Others
Segmentation by Application:
Healthcare and Medical Laboratories
Pharmaceutical Industry
Veterinary Medicine
Hazardous Waste Management
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Air Sea Containers
CIBESMED Ltd
ALEX BREUER GMBH
E3 Cortex
Berlin Packaging LLC
CFT Canada
ICC
罢丑别谤补辫补办鈩�
Serpac
Friobox
Key Questions Addressed in this Report
What is the 10-year outlook for the global Infectious Substance Packaging market?
What factors are driving Infectious Substance Packaging market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Infectious Substance Packaging market opportunities vary by end market size?
How does Infectious Substance Packaging break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Substance Packaging Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Infectious Substance Packaging by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Infectious Substance Packaging by Country/Region, 2020, 2024 & 2031
2.2 Infectious Substance Packaging Segment by Type
2.2.1 UN2814
2.2.2 UN2900
2.2.3 UN3373
2.2.4 Others
2.3 Infectious Substance Packaging Sales by Type
2.3.1 Global Infectious Substance Packaging Sales Market Share by Type (2020-2025)
2.3.2 Global Infectious Substance Packaging Revenue and Market Share by Type (2020-2025)
2.3.3 Global Infectious Substance Packaging Sale Price by Type (2020-2025)
2.4 Infectious Substance Packaging Segment by Application
2.4.1 Healthcare and Medical Laboratories
2.4.2 Pharmaceutical Industry
2.4.3 Veterinary Medicine
2.4.4 Hazardous Waste Management
2.5 Infectious Substance Packaging Sales by Application
2.5.1 Global Infectious Substance Packaging Sale Market Share by Application (2020-2025)
2.5.2 Global Infectious Substance Packaging Revenue and Market Share by Application (2020-2025)
2.5.3 Global Infectious Substance Packaging Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Infectious Substance Packaging Breakdown Data by Company
3.1.1 Global Infectious Substance Packaging Annual Sales by Company (2020-2025)
3.1.2 Global Infectious Substance Packaging Sales Market Share by Company (2020-2025)
3.2 Global Infectious Substance Packaging Annual Revenue by Company (2020-2025)
3.2.1 Global Infectious Substance Packaging Revenue by Company (2020-2025)
3.2.2 Global Infectious Substance Packaging Revenue Market Share by Company (2020-2025)
3.3 Global Infectious Substance Packaging Sale Price by Company
3.4 Key Manufacturers Infectious Substance Packaging Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Infectious Substance Packaging Product Location Distribution
3.4.2 Players Infectious Substance Packaging Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Infectious Substance Packaging by Geographic Region
4.1 World Historic Infectious Substance Packaging Market Size by Geographic Region (2020-2025)
4.1.1 Global Infectious Substance Packaging Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Infectious Substance Packaging Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Infectious Substance Packaging Market Size by Country/Region (2020-2025)
4.2.1 Global Infectious Substance Packaging Annual Sales by Country/Region (2020-2025)
4.2.2 Global Infectious Substance Packaging Annual Revenue by Country/Region (2020-2025)
4.3 Americas Infectious Substance Packaging Sales Growth
4.4 APAC Infectious Substance Packaging Sales Growth
4.5 Europe Infectious Substance Packaging Sales Growth
4.6 Middle East & Africa Infectious Substance Packaging Sales Growth
5 Americas
5.1 Americas Infectious Substance Packaging Sales by Country
5.1.1 Americas Infectious Substance Packaging Sales by Country (2020-2025)
5.1.2 Americas Infectious Substance Packaging Revenue by Country (2020-2025)
5.2 Americas Infectious Substance Packaging Sales by Type (2020-2025)
5.3 Americas Infectious Substance Packaging Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Substance Packaging Sales by Region
6.1.1 APAC Infectious Substance Packaging Sales by Region (2020-2025)
6.1.2 APAC Infectious Substance Packaging Revenue by Region (2020-2025)
6.2 APAC Infectious Substance Packaging Sales by Type (2020-2025)
6.3 APAC Infectious Substance Packaging Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Infectious Substance Packaging by Country
7.1.1 Europe Infectious Substance Packaging Sales by Country (2020-2025)
7.1.2 Europe Infectious Substance Packaging Revenue by Country (2020-2025)
7.2 Europe Infectious Substance Packaging Sales by Type (2020-2025)
7.3 Europe Infectious Substance Packaging Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Substance Packaging by Country
8.1.1 Middle East & Africa Infectious Substance Packaging Sales by Country (2020-2025)
8.1.2 Middle East & Africa Infectious Substance Packaging Revenue by Country (2020-2025)
8.2 Middle East & Africa Infectious Substance Packaging Sales by Type (2020-2025)
8.3 Middle East & Africa Infectious Substance Packaging Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Infectious Substance Packaging
10.3 Manufacturing Process Analysis of Infectious Substance Packaging
10.4 Industry Chain Structure of Infectious Substance Packaging
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Infectious Substance Packaging Distributors
11.3 Infectious Substance Packaging Customer
12 World Forecast Review for Infectious Substance Packaging by Geographic Region
12.1 Global Infectious Substance Packaging Market Size Forecast by Region
12.1.1 Global Infectious Substance Packaging Forecast by Region (2026-2031)
12.1.2 Global Infectious Substance Packaging Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Infectious Substance Packaging Forecast by Type (2026-2031)
12.7 Global Infectious Substance Packaging Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Air Sea Containers
13.1.1 Air Sea Containers Company Information
13.1.2 Air Sea Containers Infectious Substance Packaging Product Portfolios and Specifications
13.1.3 Air Sea Containers Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Air Sea Containers Main Business Overview
13.1.5 Air Sea Containers Latest Developments
13.2 CIBESMED Ltd
13.2.1 CIBESMED Ltd Company Information
13.2.2 CIBESMED Ltd Infectious Substance Packaging Product Portfolios and Specifications
13.2.3 CIBESMED Ltd Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CIBESMED Ltd Main Business Overview
13.2.5 CIBESMED Ltd Latest Developments
13.3 ALEX BREUER GMBH
13.3.1 ALEX BREUER GMBH Company Information
13.3.2 ALEX BREUER GMBH Infectious Substance Packaging Product Portfolios and Specifications
13.3.3 ALEX BREUER GMBH Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ALEX BREUER GMBH Main Business Overview
13.3.5 ALEX BREUER GMBH Latest Developments
13.4 E3 Cortex
13.4.1 E3 Cortex Company Information
13.4.2 E3 Cortex Infectious Substance Packaging Product Portfolios and Specifications
13.4.3 E3 Cortex Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 E3 Cortex Main Business Overview
13.4.5 E3 Cortex Latest Developments
13.5 Berlin Packaging LLC
13.5.1 Berlin Packaging LLC Company Information
13.5.2 Berlin Packaging LLC Infectious Substance Packaging Product Portfolios and Specifications
13.5.3 Berlin Packaging LLC Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Berlin Packaging LLC Main Business Overview
13.5.5 Berlin Packaging LLC Latest Developments
13.6 CFT Canada
13.6.1 CFT Canada Company Information
13.6.2 CFT Canada Infectious Substance Packaging Product Portfolios and Specifications
13.6.3 CFT Canada Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CFT Canada Main Business Overview
13.6.5 CFT Canada Latest Developments
13.7 ICC
13.7.1 ICC Company Information
13.7.2 ICC Infectious Substance Packaging Product Portfolios and Specifications
13.7.3 ICC Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ICC Main Business Overview
13.7.5 ICC Latest Developments
13.8 罢丑别谤补辫补办鈩�
13.8.1 罢丑别谤补辫补办鈩� Company Information
13.8.2 罢丑别谤补辫补办鈩� Infectious Substance Packaging Product Portfolios and Specifications
13.8.3 罢丑别谤补辫补办鈩� Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 罢丑别谤补辫补办鈩� Main Business Overview
13.8.5 罢丑别谤补辫补办鈩� Latest Developments
13.9 Serpac
13.9.1 Serpac Company Information
13.9.2 Serpac Infectious Substance Packaging Product Portfolios and Specifications
13.9.3 Serpac Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Serpac Main Business Overview
13.9.5 Serpac Latest Developments
13.10 Friobox
13.10.1 Friobox Company Information
13.10.2 Friobox Infectious Substance Packaging Product Portfolios and Specifications
13.10.3 Friobox Infectious Substance Packaging Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Friobox Main Business Overview
13.10.5 Friobox Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂